An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
The Alzheimer’s Disease Research Center (ADRC) at the University of Pittsburgh is one of the country’s hubs for researchers ...
Washington University-led research shows a small group of participants in an Alzheimer’s study experienced a significant ...
An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
The Trump administration has canceled funding for an ongoing 30-year, nationwide study tracking patients with prediabetes and ...
The Trump administration has cut NIH funding levels and paused new and existing grants from the agency, which totalled $35 ...
An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in their 40s or 50s, according to new findings from ongoing research now caught ...
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...
The National Institutes of Health are the world’s largest funder of medical research, distributing $35 billion in in grants ...
What Gutting NIH Research Means for Americans with Cancer, Alzheimer's, & Other Diseases” will spotlight patients, universities, and researchers impacted by ...